{"disease":{"id":"pelvic-gynecological-cancer","name":"pelvic gynecological cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05731661","title":"Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":99,"lead_sponsor_name":"Centre Francois Baclesse","has_results":false},{"nct_id":"NCT06816095","title":"Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Bernardino Clavo, MD, PhD","has_results":false},{"nct_id":"NCT03281018","title":"Preoperative Hypnosis in Gynecology","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}